PHS
ANAB icon

PFM Health Sciences’s AnaptysBio ANAB Stock Holding History

PFM Health Sciences’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-605,345
Closed -$38.6M – 95
2018
Q4 		$38.6M Sell
605,345
-449,016
-43% -$33.4M 1.03% 40
2018
Q3 		$105M Buy
1,054,361
+916,023
+662% +$76M 1.54% 18
2018
Q2 		$9.83M Buy
138,338
+67,984
+97% +$5.7M 0.15% 101
2018
Q1 		$7.32M Sell
70,354
-355,542
-83% -$40.1M 0.15% 84
2017
Q4 		$42.9M Buy
+425,896
New +$31.4M 1.02% 43

Other funds holding ANAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

PFM Health Sciences's ANAB Position: Q1 2019 in Review

PFM Health Sciences sold out of AnaptysBio (ANAB) in Q1 2019, closing a stake of 605,345 shares — an estimated $38.6M sold.

PFM Health Sciences first reported a position in ANAB in Q4 2017 and held it in 5 quarters. The position peaked at $105M in Q3 2018. 129 funds tracked by Wall St. Rank hold ANAB as of Q1 2019.

  • PFM Health Sciences reported no remaining AnaptysBio position as of Q1 2019 after selling out during the quarter.
  • PFM Health Sciences sold 605,345 AnaptysBio shares in Q1 2019, an estimated $38.6M.
  • PFM Health Sciences first reported a position in AnaptysBio in Q4 2017 and held it in 5 quarters.
  • PFM Health Sciences's AnaptysBio position peaked at $105M in Q3 2018.
  • 129 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2019.

Based on PFM Health Sciences's 13F filing for Q1 2019, filed 15 May 2019.